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Tetracera akara, a climbing shrub locally called Nennalvalli or Pattuvalli, is an ethnomedicinal plant used by Kani tribe 
of Kerala to treat chronic liver disorders and inflammatory conditions.  The present study was aimed to evaluate the 
hepatoprotective activity of ethanolic extract of roots of Tetracera akara root on D-Galactosamine induced hepatotoxicity in 
Wistar rats. Hepatotoxicity was induced in Wistar rats by intraperitoneal injection of D-GalN (400 mg/kg in saline) in 
Wistar rats. Ethanolic extract of T. akara root (TA ETH) was administered to the experimental rats in varying doses of  
(50, 150 and 300 mg/kg/day), p. o. for 7 days. The hepatoprotective effect was evaluated by the estimation of biochemical 
markers of hepatic injury, anti-oxidant status of the liver by estimating hepatic catalase, superoxide dismutase, glutathione 
and malondialdehyde, gene and protein expression level of inflammatory marker genes and histopathological evaluation of 
experimental animals. Administration of TA ETH (150 and 300 mg/kg) significantly (P ≤0.05) restored the levels of serum 
bilirubin, protein and other hepatic enzymes almost comparable to the standard drug Silymarin-treated groups. The levels of 
antioxidant enzymes like SOD and CAT were elevated and lipid peroxidation was inhibited as evident from the reduced 
levels of MDA. The gene expression studies by quantitative PCR method showed that TA ETH significantly (P ≤0.05) 
downregulated pro inflammatory cytokines, inflammatory COX-2 genes and upregulated IL 10 gene levels in D-GalN 
induced liver tissue, which was further confirmed in protein estimation by ELISA method. The histopathological 
observations were in correlation with the biochemical findings showing the presence of normal hepatic architecture, which 
further evidenced the hepatoprotective effect of TA ETH. Ethanolic extract of the root of T. akara possesses significant 
hepatoprotective activity mainly by scavenging reactive free radicals, boosting the endogenous antioxidant system in liver 
and inhibiting pro-inflammatory mediator like TNF α, COX-2, iNOS and promoting the anti-inflammatory IL 10, thus 
substantiating the tribal claim. 
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Liver is the most important organ of metabolism and 
acute liver injury is generally caused by drug abuse, 
virus infection, heavy alcohol consumption, etc., which 
is associated with a high mortality rate due to lack of 
effective preventions or therapeutic strategies1. Among 
the numerous models of acute liver injury, D-GalN is a 
highly specific hepatotoxic agent that induces liver 
injury closely resembling viral hepatitis in its 
morphological and functional features2. It has been 
commonly used as a mature platform to investigate the 
mechanisms underlying clinical liver disease and to 
develop effective hepatoprotective approaches. 
Toxicity induced by D-GalN is liver specific and does 
not affect any other organs of the body3. D-GalN traps 
uracil nucleotides by its toxic intermediary metabolites 
(UDP-galactosamine and UDP-glucosamine) in the 
liver, thus resulting in the depletion of hepatic uridine 
triphosphate, UDP-glucose and UDP-galactose, which 
are essential materials for the biosynthesis of 
macromolecules such as nucleic acids and proteins4. 
Intense galactosamination results in activation of mast 
cells to release histamine and loss of activity of the 
calcium pump which leads to a consequent increase in 
the intracellular calcium and is considered as one of the 
major reasons for cell death in D-Gal N induced 
hepatotoxicity5. D-Gal N stimulates Kupffer cells to 
produce inflammatory factors, such as tumor necrosis 
factor-α (TNF-α), cyclooxygenase-2 (COX-2) and 
inducible nitric oxide synthase (iNOS), which causes 
cell death in various ways including the promotion of 
oxidative stress and the inflammatory process. 
Tetracera akara (Burm. f.) Merr. (Fam.: 
Dilleniaceae) is a woody climber, locally known as 
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‘Pattuvalli’ or ‘Nennalvalli’, distributed in the 
Western Ghats region of Kerala and Tamil Nadu. The 
roots of T. akara is used by the Kani tribe of Kerala to 
cure liver diseases. The medicinal use of T. akara was 
first reported by Dr. Saradamma et al.6 from 
JNTBGRI in 1987. In Kani tribes, the paste of the 
fresh root of ‘Pattuvalli’ is administered orally in 
empty stomach to cure chronic liver disorders and 
inflammatory conditions6. The result obtained from 
our previous studies like comparative in vitro 
antioxidant analysis revealed that T. akara ethanolic 
extract is rich in bioactive phytoconstituents, phenols 
and flavonoids, and is safe for oral administration in 
experimental animals7,8. Though the antihepatotoxic 
potential of ethanolic extract of T. akara has been 
demonstrated against paracetamol over dosage in 
Wistar rats.  it still requires more scientific evidence 
for its hepatoprotection potential in different animal 
models9.The protective effect of T. akara against  
D-Gal-induced liver injury has not been reported. In 
the present study, we have investigated the protective 
effects of ethanolic extract of roots of Tetracera 
akara against D-galactosamine induced 
hepatotoxicity in Wistar rats and its potential 
mechanisms of action. 
 
Materials and Methods 
Collection and authentication of plant material 
Tetracera akara (Burm. f.) Merr. roots were 
collected from Kottoor (N 08º 35’ 03.8’’, E 77º 10’ 
54.8’’ and altitude 585m), Thiruvananthapuram 
district of Kerala, India, and authenticated by the 
plant taxonomist of JNTBGRI, Palode. Voucher 
specimens was deposited at the Institute’s Herbarium 
(TBGT 86868 dated 08/08/2015). 
 
Preparation of ethanolic extract of T. akara root 
The collected roots were washed in running water, 
shade dried and powdered. The powder was serially 
extracted with hexane followed by chloroform and 
then by 95 % ethanol for 48 h, using a Soxhlet 
apparatus. The third solvent fraction was then filtered 
and the filtrate was concentrated under reduced 
pressure in rotary evaporator, to get the ethanolic 
fraction with 9.5 % w/w of yield. The dry residue was 
stored at 4ºC, and at the time of use, was suspended in 
0.5% v/v Tween-80. This ethanolic extract was 
referred to as TA ETH.  
 
Animals  
Wistar rats (150-175 g) were obtained from the 
Institute’s Animal House. All the animals were housed 
in polypropylene cages under standard conditions at 
temperature 25±2°C, relative humidity 60±10%, room 
air changes 15±3 times/h and 12 h light-dark cycles, 
fed commercial rat feed (Lipton India Ltd; Mumbai, 
India) and boiled water ad libitum. Animals were 
acclimatized for 1 week before the initiation of an 
experiment. The study was carried out according to 
National Institute of Health (NIH) guidelines, after 
getting the approval of the Institute’s Animal Ethics 
Committee (No. B1/03/2015/EMEP-11). 
 
Commercial kits 
Commercial kits for the estimation of aspartate 
transaminase (AST), alanine transaminase (ALT), 
alkaline phosphatase (ALP), γ-glutamyl transferase 
(GGT), serum bilirubin (SB), triglycerides (TGL), 
total cholesterol (TC) and total protein (TP) were 
purchased from Coral Clinical System, Goa, India. 
 
D-galactosamine (D-GalN) induced hepatotoxicity 
D-galactosamine induced hepatotoxicity was 
carried out according to the procedure of Lin  
et al.10. Wistar rats were divided into six groups of six 
animals each. Group I, the normal control group was 
given a single daily dose of 0.5% Tween-80 for 5 
days and injected with a single dose of saline  
(10 mL/kg, i.p.) on the 6th day. Group II,  
D-galactosamine control group was given a single 
daily dose of 0.5% Tween-80 for five days and 
injected with D-GalN (400 mg/kg in saline, i. p) on 
the 6th day. Groups III, IV and V, the drug treated 
groups were administered TA ETH reconstituted in 
0.5% Tween-80 at dosages 50, 150 and 300 mg/kg, 
p.o., respectively. Group VI, the standard group was 
administered a single daily dose of Silymarin  
(100 mg/kg, p.o.) for 5 days and on the 6th day dosed 
with D-GalN as Group II. On the 7th day, 24 h after 
D-GalN treatment, all the animals were sacrificed by 
carbon dioxide inhalation and blood samples were 
collected from the carotid artery for evaluating plasma 
markers of hepatic injury and liver tissue were 
collected for evaluating the antioxidant status of liver, 
gene expression studies and histopathological studies. 
 
Estimation of serum biochemical parameters 
The collected blood samples in test tubes without 
EDTA were allowed to coagulate for 1 h at room 
temperature (25±2°C). It was centrifuged at 1500 rpm 
for 15 min at 37°C to separate the serum which was 
then subjected to the assay of plasma markers of 
hepatic injury like alanine transaminase (ALT), 
aspartate transaminase (AST), alkaline phosphatase 
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(ALP), γ-glutamyl transferase (GGT) and L-lactate 
dehydrogenase (LDH) were determined. Total serum 
protein (TP), albumin (ALB), total bilirubin (TBIL) 
and glucose (GLU) were also estimated using 
commercial kits purchased from Coral Clinical 
system, Goa, India. 
 
Estimation of liver tissue parameters 
Liver samples of all groups were weighted and 
homogenized separately using a tissue homogenizer. 
One portion (10% w/v) was homogenized in 50 mM, 
pH 7.4 phosphate buffer saline (PBS) which was 
centrifuged at 6000×g for 15 min at 3°C to remove 
the cell debris, unbroken cells, nuclei and 
erythrocytes11. The supernatant was used for the 
estimation of oxidative stress markers in liver like 
catalase (CAT), superoxide dismutase (SOD), reduced 
glutathione (GSH) and malondialdehyde (MDA) by 
comparing with standard curve generated from known 
amount of standards purchased from Thermo Fisher 
Scientific, USA.  
 
Estimation of liver catalase 
Catalase activity was measured according to the 
method described by Aebi12. Supernatant (0.1 mL) 
was added to a cuvette containing 1.9 mL of 50 mM 
phosphate buffer (pH 7.0). Reaction was started by 
addition of 1.0 mL of freshly prepared 30 mM H2O2. 
The rate of decomposition of H2O2 was measured 
spectrophotometrically by changes in absorbance at 
240 nm. Results were expressed as IU of CAT 
activity/g wet tissue and the absorbance values were 
compared with a standard curve generated from 
known amount of catalase. 
 
Estimation of superoxide dismutase 
Superoxide radicals react with tetrazolium in the 
presence of NADH and produce formazan blue. SOD 
removes the superoxide radicals and inhibits the 
formation of formazan blue. The intensity of colour is 
inversely proportional to the activity of the enzyme. 
The reaction mixture contained 1.2 mL sodium 
pyrophosphate buffer (pH 8.3, 0.025 mol/L), 0.1 mL 
phenazine methosulphate (186 mmol/L), 0.3 mL 
nitroblue tetrazolium (NBT) (300 mmol/L), 0.2 mL 
NADH (780 mmol/L) and approximately diluted 
enzyme preparations and water in a total volume of  
3 mL. After incubation at 30°C for 90 s, the reaction 
was terminated by adding 1 mL glacial acetic acid. 
The reaction was stirred vigorously and shaken with  
4 mL n-butanol. The colour intensity of the 
chromogen in the butanol layer was measured at  
560 nm against n-butanol and concentration of SOD 
were expressed as U/mg protein. The absorbance 
values were compared with a standard curve 
generated from known amount of SOD13. 
 
Estimation of reduced glutathione 
Homogenized rat liver samples (10% w/v), 0.2 mL 
were mixed with 1.8 mL of 1 mM EDTA solution. To 
this, 3 mL precipitating reagent (1.67 g of met 
phosphoric acid, 0.2 g of EDTA disodium salt, 30 g 
sodium chloride in 1 L distilled water) was added, 
mixed thoroughly and kept for 5 min before 
centrifugation. To 2 mL of the supernatant, 4.0 mL of 
0.3 M disodium hydrogen phosphate solution and  
1.0 mL of DTNB [5, 5 dithio-bis (2-nitro benzoic 
acid)] reagent was added and absorbance was read at 
412 nm. The absorbance values were compared with a 
standard curve generated from known amount of 
GSH14. 
 
Estimation of liver malondialdehyde 
Malondialdehyde (MDA) in the rat liver was 
estimated by the modified procedure of Ohkawa  
et al.15. Supernatant (1 mL) was mixed with 100 μL of 
8.1% sodium dodecyl sulfate (SDS), 600 μL of 20% 
acetic acid solution and was kept for 2 min at room 
temperature. Then 600 μL of 0.8% solution of freshly 
prepared thiobarbituric acid (TBA) was added, heated 
at 95°C for 60 min in a water bath and cooled with ice 
cold water at 4°C. A mixture of n-butanol and 
pyridine (15:1 v/v) were added, shaken vigorously 
and centrifuged at 10,000 rpm for 5 min. The 
absorbance of the organic layer was measured against 
blank at 532 nm. The amount of MDA (thiobarbituric 
acid reactive substance) was calculated using a molar 
extinction coefficient 1.56×105 M-1cm-1 and 
reported as nmoles of MDA/g tissue. 
 
Gene expression studies using Quantitative PCR (qPCR) 
analysis 
Total RNA was extracted from the cells using 
TRIzol reagent (Sigma-Aldrich, USA) according to 
the supplier’s protocol which was then treated with 
RNase free DNase I. The purity and the concentration 
of total RNA was determined using Qubit 3.0 (Life 
technologies, USA) flurimetric analysis. cDNA was 
synthesized using Verso cDNA synthesis kit (Thermo 
Fisher Scientific, USA). The mRNA levels of various 
genes were evaluated by Quantitative Real Time 
Polymerase Chain Reaction (qRT-PCR) using a 
Dynamo flash SYBR Green RT-PCR Kit (Applied 
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Biosystems, USA) and each sample was assessed in 
triplicate. qPCR cycling program was carried out 
according to manufacturer’s protocol and the results 
were analysed using Applied Biosystems step-one 
data analysis software package. The primer sequence 
used for the study were shown in Table 1 and relative 
expression levels of TNFα, COX-2, IL-10 and iNOS 
were calculated relative to GAPDH (as house-keeping 
gene) using the comparative cycle threshold method. 
Here gene expression level of a particular gene of 
interest in drug-treated groups (toxin control, standard 
drug treated and TA ETH treated) were compared to 
that in untreated (normal control) sample. 
Comparative ΔΔ CT method was followed to study 
the effect of drug treatment on gene expression and 
the amount of target, normalized to an endogenous 
control and relative to a calibrator is given by 2-ΔΔ CT 
equation16. 
 
Enzyme linked immune-sorbent assay (ELISA) 
The release of cytokines during hepatic injury were 
estimated using TNFα (Catalog # K1052-100), IL-10 
(Catalog #: ab100765) Abcam, ELISA Kits, USA. 
according to the manufacturer’s instructions. The 
inducible enzyme COX-1 and COX-2 was determined 
by Rat COX ELISA kit (Code No: 18521 & 27187) 
from IBL, USA according to manufacturer’s 
procedure.  
 
Histopathological investigations. 
Histological examination was performed in three 
animals, randomly selected from each group/sex. A 
portion of the internal organ obtained from all the 
groups was sliced into two pieces of approximately  
6 mm3 sizes and preserved in 10% formalin solution 
for 24 h. They were subjected to dehydration with 
acetone of strength 70, 80 and 100%, respectively, 
each for 1 h. Infiltration and impregnation were done 
by treatment with paraffin wax, twice each time for 1 h. 
Paraffin was used to prepare paraffin ‘L’ moulds. 
Specimens were cut into sections of 3-7 µm thickness 
and stained with Haematoxylin and Eosin (H & E). 
The thin sections of the liver were made in to 
permanent slides and examined under high resolution 
microscope with photographic facility and 
photomicrographs were taken.  
 
Result 
D-galactosamine (D- GalN) induced hepatotoxicity study 
Estimation of plasma markers of hepatic injury 
Treatment of rats with D-GalN induced 
hepatotoxicity as evident by significant (P ≤0.05) 
increase in serum AST (282.30±3.42 IU/L), ALT 
(196.22±2.18 IU/L), ALP (274.01±3.87 IU/L) GGT 
(24.63±2.15 IU/L), SB (1.50±0.09 mg/dL), TC 
(204.17±3.08 mg/dL), TGL (241.18±3.75 mg/dL) and 
decreased levels of TP (3.65±0.62 g/dL) in toxic 
control group when compared to normal group with 
AST (74.35±2.26 IU/L), ALT (68.49±2.52 IU/L), 
ALP (102.63±2.78 IU/L) GGT (6.32±0.93 IU/L), SB 
(0.49±0.07 mg/dL), TC (88.52±2.34 mg/dL), TGL 
(106.81±2.81 mg/dL) and TP (6.18±0.62 g/dL) as 
shown in Table 2. Pre-treatment with TA ETH  
(50, 150 and 300 mg/kg) caused significant (P ≤0.05) 
protection against D-GalN intoxicated rats by 
attenuating AST, ALT, ALP, GGT, SB, TC, TGL and 
TP elevation in a dose dependent manner. For all the 
eight biochemical parameters under investigation, TA 
ETH (300 mg/kg) (AST: 88.58±2.17  IU/L, ALT: 
75.16 ± 2.21  IU/L, ALP: 131.25 ± 3.40 IU/L, GGT: 
6.89±0.65 IU/L, SB: 0.68±0.04 mg/dL, TC: 
82.96±3.31  mg/dL, TGL: 125.20±1.38  mg/dL and 
TP: 5.80±0.17 g/dL) was found to be more significant 
than the lower doses studied, which is almost 
comparable to that of Silymarin (100 mg/kg) (AST: 
92.58±2.43 IU/L, ALT: 63.50±2.24 IU/L, ALP: 
120.83±2.46 IU/L, GGT: 7.39±0.42 IU/L, SB: 
0.61±0.04 mg/dL, TC: 94.72±2.18 mg/dL, TGL: 
117.12±2.35 mg/dL and TP: 5.94±0.72 g/dL), the 
standard drug used in the study.  
 
Evaluation of in vivo antioxidant status of liver 
The Catalase in liver tissue decreased significantly 
in D-GalN intoxicated animals (42.28±3.75 U/mg 
protein) of toxin group when compared to normal 
control group (154.36±5.47 U/mg protein). The SOD 
Table 1 — Primer sequence used in the study 
Target Gene Forward Sequence Reverse Sequence Amplified band 
(base pair) 
TNF-α 5′-ACT GAA CTT CGG GGT GAT TG-3′ 5′-GCT TGG TGG TTT GCT ACG AC-3′ 234 
COX-2 5′-TTC AAA TGA GAT TGT GGG AAA ATT GCT-3′ 5′-AGA TCA TCT CTG CCT GAG TAT CTT T-3′ 210 
IL-10 5′-AGA AGG ACC AGC TGG ACA AC-3′ 5′-GTC GCA GCT GTA TCC AGA GG-3′ 210 
iNOS 5′-GAGCCCTACGAGCCGTTGCC-3′ 5′-GCGAATGGTCCTGCGGCGTA-3′ 195 
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levels in the toxin group was lowered to 3.45±0.98 U/mg 
where as it was found to be 12.76±1.03 U/mg in 
normal control. GSH showed significantly  
(P ≤0.05) decreased value of 7.86±0.95 μmol/g tissue 
when compared to normal control. All groups of 
animals administered with various doses of TA ETH 
showed an increase in hepatic Catalase, SOD and 
GSH in a dose dependent manner of which TA ETH 
at 300 mg/kg showed maximum protection against  
D-GalN intoxication in animals which is evident from 
the higher levels of Catalase (132.62±5.18 U/mg 
protein), SOD (13.72±1.15 U/mg protein) and GSH 
(50.48±2.87 μmol/g tissue). The MDA levels in toxin 
control animals (58.20±3.25 μmol/g wet liver) were 
higher when compared to the normal control 
(15.44±2.12 μmol/g wet liver) and it was decreased to 
a normal level in the TA ETH treated groups where 
the maximum inhibition was obtained in (300 mg/kg) 
body wt. p.o. of TA ETH treated groups (17.59±1.82 μmol/g 
wet liver) and it was almost similar to the  
standard Silymarin (100 mg/kg) treated groups 
(19.08±2.08 μmol/g wet liver) as shown in Fig. 1. 
 
Gene expression studies using Quantitative PCR (qPCR) 
analysis 
D-GalN significantly altered the synthesis of 
inflammatory cytokine and inflammatory enzyme as 
Table 2 — Effect of TA ETH on hepatic markers of liver injury in D-GalN induced acute liver damage in Wistar rats 
 Parameters 
AST 
(IU/L) 
ALT 
(IU/L) 
ALP 
(IU/L) 
GGT 
(U/L) 
SB 
(mg/dL) 
TC 
(mg/dL) 
TGL 
(mg/dL) 
TP 
(g/dL) 
Normal control 74.35± 
2.26 
68.49± 
2.52 
102.63± 
2.78 
6.32± 
0.93 
0.49± 
0.07 
88.52± 
2.34 
106.81± 
2.81 
6.18± 
0.62 
Toxin-D-GalN 
(400 mg/kg) 
282.30± 
3.42* 
196.22± 
2.18* 
274.01± 
3.87* 
24.63± 
2.15* 
1.50± 
0.09* 
204.17± 
3.08* 
241.18± 
3.75* 
3.65± 
0.62* 
D-GalN+STD Silymarin 
(100 mg/kg) 
92.58± 
2.43** 
63.50± 
2.24** 
120.83± 
2.46** 
7.39± 
0.42** 
0.61± 
0.04** 
94.72± 
2.18** 
117.12± 
2.35** 
5.94± 
0.72** 
D-GalN+TA ETH 
(50 mg/kg) 
238.42± 
2.54 
167.43± 
2.17 
229.37± 
2.72 
19.81± 
1.70 
1.21± 
0.06 
189.63± 
2.67 
196.56± 
2.93 
3.96± 
0.26 
D-GalN+TA ETH 
(150 mg/kg) 
137.84± 
1.52** 
96.33± 
2.48** 
149.65± 
2.53** 
10.64± 
1.46** 
0.76± 
0.05** 
118.60± 
3.67** 
135.31± 
1.65** 
5.01± 
0.38** 
D-GalN+TA ETH 
(300 mg/kg) 
88.58± 
2.17** 
75.16± 
2.21** 
131.25± 
3.40** 
6.89± 
0.65** 
0.68± 
0.04** 
82.96± 
3.31** 
125.20± 
1.38** 
5.80± 
0.17** 
[Values are expressed as mean ± SEM of six values, one way ANOVA followed by Dunnett’s multiple comparison test, *P ≤0.05
compared to normal control, **P ≤0.05 compared to D-GalN control] 
 
 
 
Fig. 1 — Effect of ethanolic extract of roots of Tetracera akara (TA ETH) on hepatic CAT, SOD, GSH and MDA of Wistar rats in 
D-GalN induced hepatotoxicity study. [Values are expressed as mean ± SEM, n=6, one way ANOVA followed by Dunnett’s multiple 
comparison test, * P ≤0.05 compared to normal control, *** P ≤0.05 compared to D-GalN toxin control] 
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evident from the comparative gene expression study 
in the experimental animals. The expression level of 
pro inflammatory cytokine like TNFα was highly 
elevated, whereas the anti-inflammatory cytokine,  
IL-10 expression was downregulated in the toxin 
group when compared with the normal control. The 
inflammatory enzyme COX-2 and iNOS expression in 
the toxin control was also elevated when compared to 
normal, indicating severe inflammation and onset of 
hepatic damage. The administration of TA ETH 
significantly (P ≤0.05) downregulated the gene 
expression pro inflammatory cytokines and 
inflammatory enzyme, when compared to the toxin 
group and the maximum protections was offered by 
TA ETH at (300 mg/kg) as shown in Fig. 2 (A1-A4). 
The anti-inflammatory IL 10 gene was upregulated in 
a dose dependent manner in drug treated group. TA 
ETH at 300 mg/kg body wt. treated animals showed 
reduced fold change of 0.61±0.16 for TNF-α, 
1.98±0.18 for COX-2, 1.14±0.15 for iNOS and 
1.75±0.35 for IL 10 indicating lower hepatic damage 
and inflammatory conditions. 
 
 
Fig. 2 — (A1, A2, A3 & A4): Effect of ethanolic extract of roots of Tetracera akara (TA ETH) on expression of TNFα, COX-2, iNOS, 
IL-10 genes; and (B1, B2, B3 & B4): Effect of TA ETH on protein level expression of TNFα, COX-2, COX-1, IL-10 in liver tissue of 
Wistar rats with D-GalN induced acute hepatic damage. [Values are expressed as mean ± SEM, n=6, one way ANOVA followed by
Dunnett’s multiple comparison test, * P ≤0.05 compared to normal control, *** P ≤0.05 compared to D-GalN toxin control] 
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Enzyme linked immune-sorbent assay (ELISA). 
The results obtained for TNFߙ, COX 1, COX 2 and 
IL 10 protein expression in D-GalN induced liver 
tissues were in coordination with that of the gene 
expression studies. The results showed that D-GalN 
induction significantly increased the level of 
inflammatory COX-2 expression, whereas the 
production of COX-1 was highly lowered. TA ETH 
administration reduced the COX-2 protein expression 
to 96.37±6.15 pg/mL which is comparable to  
the standard indomethacin treated group  
(108.46±9.82 pg/mL). When compared with the 
normal control, the protein levels of proinflammatory 
cytokine such as TNFߙ was remarkably increased, 
whereas the anti-inflammatory IL 10 levels was 
lowered in D-GalN induced toxin control as shown in 
Fig. 2 (B1-B4). Oral administration with TA ETH 
significantly (P ≤0.05) inhibited the cytokine release 
and elevated the production of IL 10 and maximum 
inhibition was obtained in 300 mg/kg dose treated 
group, almost comparable to the standard  
treated group. 
 
Histopathological investigations 
The liver histopathology of control group showed 
normal hepatic architecture with no evidence of 
microscopic abnormalities. D-GalN intoxicated 
animals in toxin group showed enlarged cell, 
vacuolated cytoplasm and large nuclei with 
condensed chromatin, ballooning degeneration, the 
loss of cellular boundaries, nuclear pycnosis, focal 
hepatic necrosis, Kupffer cell infiltration and 
congestion of hepatic sinusoids. TA ETH treated 
group appeared to reduce the Galactosamine toxicity 
as revealed by the healthy central vein and 
hepatocytes with clear cytoplasm and nuclei. The 
histological architecture of liver sections of the rats 
treated with higher dose of TA ETH showed more or 
less normal lobular pattern with a mild degree of fatty 
change, necrosis and lymphocyte infiltration which is 
almost comparable to the normal control and STD 
Silymarin groups as shown in Fig. 3. 
 
Discussion 
D-galactosamine (D- GalN) induced hepatotoxicity 
GalN inhibits the energy metabolism of 
hepatocytes17 by blocking enzymes involved in the 
transport of substrates to the mitochondria and 
modifies the phospholipid composition of membranes 
which alters the permeability of the cellular 
membrane and finally causing enzyme leakage from 
the cells18. Excessive production of free radicals 
resulting from oxidative stress can damage 
macromolecules as lipids, decrease levels of hepatic 
antioxidant enzymes and increased MDA level, a 
byproduct of lipid peroxidation19. Liver damage 
induced by D-GalN generally reflects as disturbances 
of hepatocytic metabolism, which lead to 
characteristic changes in the transport function and 
activities of serum enzymes and as leakage of 
enzymes from cells due to altered permeability of 
membranes20. The results obtained from the present 
study showed a significant increase in the serum 
levels of AST, ALT, ALP, GGT, SB, TC, TGL and a 
decrease in the production of TP in toxin control 
groups which is in accordance with the earlier 
findings21. The levels of these marker enzymes are 
proportional to the extent of hepatic damage and their 
estimation can be used for the diagnosis as an 
indicator of prognosis of the hepatic disease22. 
Hepatocellular necrosis leads to an increase in serum 
levels of both AST and ALT which are released from 
the liver into the blood stream. Among the two 
enzymes, ALT is a better index of liver injury, as liver 
ALT activity represents 90% of total enzyme activity 
present in the body. ALP activity when considered, is 
related to the hepatocyte function. ALP is a 
membrane bound glycoprotein enzyme reported to be 
involved in the transport of metabolites across the cell 
membranes, protein synthesis, synthesis of certain 
enzymes23. An increase in ALP activity is due to 
elevated synthesis in the presence of increased biliary 
pressure. The increased SB, TC and TGL in the serum 
of D-GalN induced rats were also supported by the 
earlier studies24,25. Pretreated with standard drug 
Silymarin and TA ETH restored the altered serum 
marker enzymes towards normal in experimental 
animals. The reduction of AST, ALT, ALP, GGT, SB, 
TC, TGL and increased TP towards normal values by 
the administration of TA ETH is an indication of 
stabilization of plasma membranes as well as repair of 
damage tissues caused by D-GalN. This effect is in 
perfect agreement with the fact that serum levels of 
transaminases return to normal with healing of the 
liver parenchymal cells and healing of hepatocytes 
indicating the hepatoprotective activity of T. akara 
against viral hepatitis induced by D-GalN26. 
The activities of antiperoxidative enzymes such as 
SOD and CAT have been reported to decrease in  
D-GalN hepatitis27. The results obtained showed 
decreased activities of SOD and CAT activities in 
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toxin group and the decreased activities might be a 
consequence of irreversible inactivation of enzyme 
proteins from increased free-radical production. 
Reduced levels of these enzymes will result in the 
accumulation of highly reactive free radicals, leading 
to deleterious effects such as loss of cell membrane 
integrity and membrane function28. Significant 
increases in the activities of these enzymes were 
observed in TA ETH administrated animal groups. 
The antioxidant phytoconstituents in TA ETH 
scavenges superoxide radicals and hydrogen peroxide 
radicals, which might decrease the workload of 
enzymatic antioxidants and reduce the free-radical-
mediated inactivation of enzyme proteins, and thereby 
maintaining the activities of enzymatic antioxidants. 
The non-enzymatic scavengers, such as GSH, 
scavenge residual free radicals escaping 
decomposition by the antioxidant enzymes, acting as 
the second line of defense29. Moreover, enzymatic 
antioxidants are inactivated by the excessive levels of 
free radicals and hence the presence of non-enzymatic 
antioxidants are presumably essential for the removal 
of these radicals30. Glutathione is a major non-protein 
thiol in living organisms, which play a central role in 
coordinating the antioxidant defense process in our 
body. Glutathione reacts directly with ROS and 
electrophilic metabolites, protects essential thiol 
group from oxidation and serves as a substrate for 
several enzymes including GPx31. The lowered GSH 
in D-GalN induced rats represents the increased 
utilization of GSH as a result of oxidative stress32. TA 
ETH administration improved significantly the GSH 
level mainly because of inactivation of ROS via its 
radical scavenging effects and retention of enzymic 
antioxidants in hepatocytes. Excessive production of 
free radical results in the oxidative stress, which leads 
to the damage of macromolecules and can induce in 
vivo lipid peroxidation33. MDA, a byproduct of lipid 
peroxidation was found to be elevated in toxin group, 
indicating membrane destabilization and hepatocytic 
damage. Pretreatment with TA ETH inhibited lipid 
peroxidation, suggesting that phytoconstituents in it 
exerted a stabilizing action on hepatocytic membranes 
and inhibited MDA formation. 
 
 
Fig. 3 — Effect of ethanolic extract of roots of etracera akara (TA ETH) on the histopathology of D-GalN induced liver damage in 
Wistar rats (×50, H & E staining). (A) Normal control rat liver histology showing normal hepatic architecture; (B) Toxin control rat liver 
with vacuolated cytoplasm & large nuclei with condensed chromatin, ballooning degeneration, the loss of cellular boundaries, nuclear
pycnosis, focal hepatic necrosis and Kupffer cell infiltration; (C) Standard Silymarin treated group showing almost normal hepatic 
architecture; (D & E) TA ETH (50 and 150 mg/kg) treated groups showing reduced hepatic damage in a dose depended manner; and
(F) TA ETH (300 mg/kg) treated group showing normalized hepatic architecture comparable to the standard. [SS, Sinusoidal space; BV, 
Blood vessel; HC, Hepatic cells; ST, Steatosis; KC, Kupffer cells; FD, Fatty degradation; BD, Ballooning degeneration; NP, Nuclear
pyknosis; and HN, Hepatic necrosis] 
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Inflammatory response forms a major contributing 
factor, leading to liver injury under various 
stimulations and D-GalN can activate Kupffer cells, 
leading to the release and accumulation of 
proinflammatory cytokines34. Previous studies have 
shown that regulation of the inflammatory response is 
an efficient strategy for the management of acute liver 
injury35. TNF-α has been reported as the most 
important pro inflammatory cytokine for the progress 
and development of acute liver injury and in this 
study, there was a significant difference observed 
between the toxin group and TA ETH treated group, 
indicating that the extract attenuated liver injury by 
downregulation of TNF-α expression. NO is a high 
reactive molecule synthesized by iNOS from  
L-arginine and overproduction of NO could suppress 
the growth of lymphocytes and damaging other 
normal cells or tissues leading to inflammatory 
disorder36. PGE2 is also an inflammatory mediator 
produced by COXs which exists in two forms. COX-1, 
associated with the production of prostaglandins that 
activate platelets and protect the stomach and 
intestinal lining. COX-2 is dramatically upregulated 
during inflammation and induces inflammatory 
responses such as fever and vasodilatation by 
generating PGE237. In the current study, it was found 
that the gene and protein level expression of COX-2 
was evidently increased in the rats treated with  
D-GalN indicating severe inflammation and tissue 
damage, whereas the expression of COX-1 was very 
much lowered. However, pre-administration of TA 
ETH markedly decreased COX-2 production 
compared to D-GalN-stimulated toxin control. In 
addition, TA ETH pretreatments significantly 
elevated mRNA as well as protein expression of  
IL-10 and protein level expression of COX-1 
compared to D-GalN-stimulated control. 
The histological evidence authenticated the injury 
caused by D-GalN and the protection offered by TA 
ETH to hepatocytes. Microscopical examination 
revealed loss of hepatic architecture with ballooning 
degeneration, nuclear pycnosis, focal hepatic 
necrosis, Kupffer cell infiltration and inflammatory 
collections in the central zone in D-GalN induced 
rats of toxin group. Prior oral administration with 
TA ETH extract prevented the histopathological 
changes in the liver induced by D-GalN in a dose 
dependent manner. TA ETH (300 mg/kg) treated rats 
showed normal morphology with more or less 
normal lobular pattern, necrosis and lymphocyte 
infiltration without appreciable histological 
abnormalities, comparable to the standard Silymarin 
(100 mg/kg) treated animals. The histopathological 
studies serve as a direct evidence supporting the 
result of biochemical serum parameters and 
antioxidant status of D-GalN treated animals. Thus, 
the bioactive phytoconstituents with antioxidant 
potential in TA ETH effectively scavenged the free 
radicals formed during the D-GalN metabolism and 
reduced the oxidative stress in hepatocytes. The anti-
lipid peroxidation effect of TA ETH played a major 
role in stabilizing the hepatocytic membrane, in turn 
enhanced the production, action and prevented the 
leakage of antioxidant enzymes from hepatocyte. It 
also enhanced the regeneration of hepatocytes, 
damaged by D-GalN in experimental animals. The 
protective action of TA ETH against D-GalN 
toxicity is of clinical importance because there is 
close resemblance between the multifocal necrosis 
produced by D-GalN and the lesion of viral hepatitis 
in humans and the results of this study suggest that  
T. akara could play a major role in the treatment of 
viral hepatitis. 
 
Conclusion 
Resutls of this investigation demonstrated the 
hepatoprotective potential of ethanolic extract of roots 
of Tetracera akara possibly by scavenging reactive 
free radicals, boosting the endogenous antioxidant 
system in liver, inhibiting pro-inflammatory 
mediators like TNF α, COX-2, iNOS and by 
promoting anti-inflammatory IL 10. Further research 
is required to explicate the detailed mechanism of 
action of phytoconstituents in TA ETH on acute liver 
damage for exploitation of its broader remedial usage 
and development of a therapeutic drug with least 
side effect. 
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